Literature DB >> 12725311

Association between lymph node size and metastasis in dogs with oral malignant melanoma: 100 cases (1987-2001).

Laurel E Williams1, Rebecca A Packer.   

Abstract

OBJECTIVE: To determine the association between lymph node size and metastasis and to assess measurement of lymph node size as an accurate and reliable means of tumor staging in dogs with oral malignant melanoma.
DESIGN: Retrospective study. ANIMALS: 100 dogs with histologically confirmed oral malignant melanoma. PROCEDURE: Clinical records for dogs with oral malignant melanoma were reviewed. Data regarding size and results of cytologic or histologic examination of lymph nodes were evaluated. The association between lymph node size and metastasis was determined.
RESULTS: Forty-seven (47%) dogs, of which 23 (49%) had enlarged mandibular lymph nodes, had no cytologic or histologic evidence of metastasis. Of 53 (53%) dogs with cytologic or histologic evidence of mandibular lymph node metastasis, 37 (70%) had enlarged mandibular lymph nodes, and 16 (30%) had mandibular lymph nodes of normal size. Overall, 16 of the 40 (40%) dogs with normal-sized lymph nodes had microscopic evidence of metastatic disease. Sensitivity and specificity of lymph node size as a predictor of metastasis were 70 and 51%, respectively, and the positive and negative predictive values were 62 and 60%, respectively. CONCLUSIONS AND CLINICAL RELEVANCE: Although a significant relationship was identified between lymph node size and metastasis to the lymph node, this association did not appear strong enough to be clinically relevant. Results suggest that lymph node size alone is insufficient for accurate clinical staging of oral malignant melanoma in dogs; cytologic or histologic examination of regional lymph nodes should routinely be performed, regardless of size of those nodes.

Entities:  

Mesh:

Year:  2003        PMID: 12725311     DOI: 10.2460/javma.2003.222.1234

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  19 in total

1.  Hypo-fractionated Radiation, Magnetic Nanoparticle Hyperthermia and a Viral Immunotherapy Treatment of Spontaneous Canine Cancer.

Authors:  P Jack Hoopes; Karen L Moodie; Alicia A Petryk; James D Petryk; Shawntel Sechrist; David J Gladstone; Nicole F Steinmetz; Frank A Veliz; Alicea A Bursey; Robert J Wagner; Ashish Rajan; Danielle Dugat; Margaret Crary-Burney; Steven N Fiering
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-02-22

2.  The effect of hypofractionated radiation and magnetic nanoparticle hyperthermia on tumor immunogenicity and overall treatment response.

Authors:  P Jack Hoopes; Robert J Wagner; Ailin Song; Bjorn Osterberg; David J Gladstone; Alicea A Bursey; Steven N Fiering; Andrew J Giustini
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-02-23

3.  Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti-CSPG4 vaccination: A retrospective study on 68 cases (2010-2020).

Authors:  Mariateresa Camerino; Davide Giacobino; Luca Manassero; Selina Iussich; Federica Riccardo; Federica Cavallo; Lidia Tarone; Matteo Olimpo; Elena Lardone; Marina Martano; Sara Del Magno; Paolo Buracco; Emanuela Morello
Journal:  Vet Comp Oncol       Date:  2021-09-06       Impact factor: 2.385

4.  Computed tomography features of presumed normal mandibular and medial retropharyngeal lymph nodes in dogs.

Authors:  Alexandra F Belotta; Sally Sukut; Candace Lowe; Cheryl Waldner; Elissa K Randall; Valerie S MacDonald; Jerome Gagnon; Monique N Mayer
Journal:  Can J Vet Res       Date:  2022-01       Impact factor: 0.897

5.  Treatment of Canine Oral Melanoma with Nanotechnology-Based Immunotherapy and Radiation.

Authors:  P Jack Hoopes; Robert J Wagner; Kayla Duval; Kevin Kang; David J Gladstone; Karen L Moodie; Margaret Crary-Burney; Hugo Ariaspulido; Frank A Veliz; Nicole F Steinmetz; Steven N Fiering
Journal:  Mol Pharm       Date:  2018-04-12       Impact factor: 4.939

6.  Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Authors:  A Lejeune; K Skorupski; S Frazier; I Vanhaezebrouck; R B Rebhun; C M Reilly; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-05-31       Impact factor: 2.613

7.  Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases.

Authors:  Davide Giacobino; Mariateresa Camerino; Federica Riccardo; Federica Cavallo; Lidia Tarone; Marina Martano; Alfredo Dentini; Selina Iussich; Elena Lardone; Paolo Franci; Alberto Valazza; Luca Manassero; Sara Del Magno; Raffaella De Maria; Emanuela Morello; Paolo Buracco
Journal:  Vet Comp Oncol       Date:  2021-03-22       Impact factor: 2.385

8.  Profiling of plasma metabolites in canine oral melanoma using gas chromatography-mass spectrometry.

Authors:  Mifumi Kawabe; Yuta Baba; Reo Tamai; Ryohei Yamamoto; Masayuki Komori; Takashi Mori; Shigeo Takenaka
Journal:  J Vet Med Sci       Date:  2015-05-04       Impact factor: 1.267

9.  Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.

Authors:  L A Piras; F Riccardo; S Iussich; L Maniscalco; F Gattino; M Martano; E Morello; S Lorda Mayayo; V Rolih; F Garavaglia; R De Maria; E Lardone; F Collivignarelli; D Mignacca; D Giacobino; S Ferrone; F Cavallo; P Buracco
Journal:  Vet Comp Oncol       Date:  2016-05-04       Impact factor: 2.613

Review 10.  Comparative Aspects of Canine Melanoma.

Authors:  Adriana Tomoko Nishiya; Cristina Oliveira Massoco; Claudia Ronca Felizzola; Eduardo Perlmann; Karen Batschinski; Marcello Vannucci Tedardi; Jéssica Soares Garcia; Priscila Pedra Mendonça; Tarso Felipe Teixeira; Maria Lucia Zaidan Dagli
Journal:  Vet Sci       Date:  2016-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.